GHRH receptor comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-12-13. Numbers and descriptions here follow the published literature rather than marketing material.
在临床研究之外,特沙莫瑞林常被讨论为生长激素分泌促进剂,但这一说法需要限定。它并不等同于生长激素本身,也不属于普通减重药物。部分研究关注其减少腹部脂肪和改善脂质谱的潜力,另一些研究则关注胰岛素抵抗和 IGF-1 升高等信号。这些效应的临床意义仍在评估中,尚未形成统一结论。
特沙莫瑞林是一种合成肽,其序列与人生长激素释放激素的 44 个氨基酸形式相关。它在 N 端带有反式-3-己烯酰基修饰,这一改动可减缓二肽基肽酶 IV 的降解。该化合物属于生长激素释放激素受体激动剂,可刺激垂体释放生长激素。研究文献通常将其归入合成肽类药物,而非小分子化合物。
监管记录显示,特沙莫瑞林于 2010 年在美国首次获得批准,用于人类免疫缺陷病毒感染相关的脂肪营养不良患者。批准依据来自降低内脏脂肪的临床试验,而非体重或瘦体重的普遍改善。后续出现了不同制剂版本,但其核心适应症保持一致。关于长期心血管结局和死亡率影响,现有证据仍不充分。
Pharmacodynamic studies show that tesamorelin reduces visceral adipose tissue more than subcutaneous adipose tissue in the studied population. This selectivity may relate to differences in blood flow and hormone sensitivity between fat depots. Effects on glucose metabolism and insulin sensitivity have been investigated, with some trials reporting modest changes and others showing stability. The precise relationship between growth hormone exposure, IGF-1 levels, and visceral fat loss remains an active area of analysis.
Tesamorelin binds to growth hormone-releasing hormone receptors on somatotroph cells in the anterior pituitary. Receptor activation increases intracellular cyclic AMP and promotes synthesis and secretion of growth hormone. Because the peptide mimics endogenous GHRH, it amplifies the normal pulsatile release of growth hormone rather than providing exogenous growth hormone directly. This upstream action distinguishes tesamorelin from recombinant growth hormone preparations and from growth hormone secretagogues that act at different receptors.
Stimulated growth hormone release leads to hepatic production of insulin-like growth factor 1, a key mediator of many growth hormone effects. In clinical studies, tesamorelin increased IGF-1 levels in a dose-dependent manner, although the response varies among individuals. The drug's effect on visceral fat is thought to involve growth hormone-mediated lipolysis and altered adipocyte metabolism. Muscle mass and lean body mass have also been assessed as secondary outcomes, but changes are generally smaller and less consistent than fat reductions.
| Property | Value | Notes |
|---|---|---|
| 分子类型 | 合成肽 | 含 44 个氨基酸残基的 GHRH 类似物 |
| N 端修饰 | 反式-3-己烯酰基 | 用于抵抗二肽基肽酶 IV 降解 |
| 首次批准 | 2010 年,美国 | 用于 HIV 相关脂肪营养不良 |
| 作用靶点 | 生长激素释放激素受体 | 位于垂体前叶 |
| 主要研究终点 | 内脏脂肪变化 | 非总体重或瘦体重 |
Clinical interest in tesamorelin arose from the need to address visceral adiposity in people living with HIV. Antiretroviral therapy improved survival but was associated in some patients with central fat accumulation, altered lipid profiles, and metabolic complications. This condition, often called HIV-associated lipodystrophy, involves excess visceral adipose tissue that is difficult to manage through diet and exercise alone. Investigators evaluated tesamorelin because GHRH analogs can stimulate growth hormone secretion and influence fat distribution without direct liposuction or invasive procedures.
A Phase 3 program led to regulatory approval in the United States in 2010 for reduction of excess visceral abdominal fat in adults with HIV and lipodystrophy. Subsequent studies examined effects on liver fat, muscle area, and metabolic markers, with mixed findings for some endpoints. Long-term cardiovascular outcomes and effects on mortality remain uncertain because most trials were relatively short and focused on imaging-based fat measurements. Use in populations without HIV has been studied experimentally but is not part of the approved indication.
Tesamorelin is a synthetic analog of growth hormone-releasing hormone, a peptide hormone produced by the hypothalamus. The molecule retains the 44-amino-acid sequence of human GHRH and carries a trans-3-hexenoyl modification at its N-terminus. This modification increases resistance to enzymatic degradation and extends the peptide's functional stability relative to native GHRH. The compound is supplied as a lyophilized powder for reconstitution and subcutaneous administration in clinical settings. Its development code was TH9507, and it belongs to the GHRH analog class. It is not a growth hormone product; instead, it acts upstream to stimulate endogenous growth hormone release.
Whether the drug improves hard clinical outcomes is not settled. No completed trial has shown a reduction in heart attacks or strokes among treated patients, although a dedicated cardiovascular outcomes study has been discussed in the literature. Investigators have also examined hepatic fat in people with HIV and fatty liver disease, cognitive measures in small cohorts, and changes in bone density. Regulatory labeling emphasizes monitoring of insulin-like growth factor 1 because supraphysiologic levels raise questions about tissue growth, and the clinical significance of that signal remains an open question rather than a demonstrated harm.
Binding of tesamorelin to the growth hormone-releasing hormone receptor on anterior pituitary somatotrophs activates a Gs protein pathway, raises cyclic AMP, and triggers release of stored growth hormone into the bloodstream. Because the analogue resists dipeptidyl peptidase-4, its plasma residence time exceeds that of native GHRH, producing a larger and more sustained secretory signal. The released growth hormone then acts on the liver and peripheral tissues to raise insulin-like growth factor 1, which feeds back on the hypothalamus and pituitary. This axis explains both the intended effects on fat distribution and the biological markers used to track them.
Tesamorelin occupies a narrow position among agents that act on the growth hormone axis. Unlike growth hormone itself, which is given as replacement, it stimulates the pituitary to release the hormone in pulses, so the downstream increase in insulin-like growth factor 1 depends on intact somatotroph function. Other peptides in the same family include shorter GHRH fragments and synthetic secretagogues with different stability profiles. Several points remain unresolved, including whether the reduction in visceral fat translates into fewer cardiovascular events, what happens to metabolic markers after long-term use, and how the drug compares with lifestyle or surgical approaches.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone family and contains the same forty-four amino acid sequence as endogenous GHRH, extended at the amino terminus by a trans-3-hexenoyl group. That small fatty acid modification protects the peptide from rapid cleavage by dipeptidyl peptidase-4, the enzyme that shortens the half-life of native GHRH to only a few minutes. Chemically the compound is produced by solid-phase peptide synthesis, purified by chromatography, and supplied as a sterile lyophilized powder for reconstitution.
Questions remain about how much of the observed fat reduction reflects direct GHRH-receptor signaling versus the downstream growth hormone and IGF-1 surge. It is also unclear whether the compound produces meaningful benefit in populations without lipodystrophy, since trials in cognitive impairment did not reach their stated goals. Long-term effects on glucose metabolism and on cardiovascular outcomes are not fully characterized. Published work generally describes effects on surrogate markers rather than on hard clinical endpoints, and independent replication of some findings is limited.
Tesamorelin acts on the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in intracellular cyclic AMP, which in turn opens ion channels and raises calcium concentrations, leading to release of stored growth hormone into the bloodstream. Because the peptide works through the same receptor as the body's own GHRH, the resulting secretion follows a pulsatile pattern rather than a continuous elevation. The N-terminal modification slows enzymatic breakdown, so the signal persists longer than it would with the unmodified hormone.
Growth hormone released from the pituitary stimulates the liver and other tissues to produce insulin-like growth factor 1, a stable circulating protein that serves as a practical marker of activity. Clinical studies therefore track IGF-1 concentrations alongside the hormone itself, and they commonly measure body composition with imaging rather than relying on body weight alone. Visceral adipose tissue, the fat surrounding abdominal organs, is quantified by computed tomography in the studies that supported approval. Adverse effects reported in trials include injection-site reactions, joint pain, and increases in blood glucose, which is why monitoring accompanies use.
On January 18, 2015, Alice in Chains performed in the halftime show of the NFC Championship Game between the Seattle Seahawks and the Green Bay Packers at CenturyLink Field in Seattle. Cantrell is a lifelong Seahawks fan and often attends their games. In August 2015, Bassist Mike Inez said that the band had been "throwing around riffs for a new record" and "taking it nice and slow". The band toured in the summer of 2015 and the summer of 2016, including select shows opening for Guns N' Roses as part of the Not in This Lifetime... Tour. The band finished their 2016 tour with a concert at the Grand Sierra Resort and Casino in Reno, Nevada on October 8, 2016. In November 2016, Alice in Chains released a cover of the Rush song "Tears", which was included in the 40th anniversary release of the album 2112. The home video Live Facelift was released on vinyl for the first time on November 25, 2016, as part of Record Store Day's Black Friday event. The album features six songs and only 5000 copies were issued. To celebrate the tenth anniversary of Record Store Day, on April 22, 2017, Legacy Recordings released "Get Born Again"/"What the Hell Have I", a special 45 RPM double 7" single featuring four tracks remastered and available on vinyl for the first time, "What the Hell Have I", "A Little Bitter", "Get Born Again" and "Died".
According to a study by Colombia's National Centre for Historical Memory, 220,000 people died in the conflict between 1958 and 2013, most of them civilians (177,307 civilians and 40,787 fighters), and more than five million civilians were forced from their homes between 1985 and 2012, generating the world's second-largest population of internally displaced persons (IDPs). 16.9% of the population in Colombia has been a direct victim of the war. 2.3 million children have been displaced from their homes and 45,000 children have been killed, according to national figures cited by UNICEF. In total, one in three of the 7.6 million registered victims of the conflict are children and 8,000 minors have disappeared since 1985. A Special Unit was created to search for persons deemed as missing within the context of and due to the armed conflict. As of April 2022, the Single Registry of Victims reported 9,263,826 victims of the Colombian conflict, with 2,048,563 of them being children. Approximately 80% of those killed in the conflict have been civilians. In 2022, the Truth Commission of Colombia estimated that paramilitaries were responsible for 45% of civilian deaths, the guerrillas for 27%, and state forces for 12%, with the remaining 16% attributable to other groups or mixed responsibility. On June 23, 2016, the Colombian government and the FARC rebels signed a historic ceasefire deal, bringing them closer to ending more than five decades of conflict.
== Deployments == In Côte d'Ivoire the system has been implemented across a national network of clinical laboratories as part of an HIV and public-health laboratory data programme. In 2020, the United Nations Development Programme (UNDP) country office in Mauritius acted as liaison to implement OpenELIS at the country's Central Health Laboratory during the COVID-19 pandemic; UNDP reported that the deployment reduced the staff required to process and report test data and avoided a substantially larger procurement cost. Implementations have also been reported in Kenya.
The stringed crowns and the trays used in manual sorting are shown in the figure. The destination tray is moved step by step in the direction of the arrow. The crowns are transferred in groups from the slots of the source tray into the all opposite slots of the destination tray. The transfers are directed by computer and the products are identified by the positions of the crowns occupied on the final strings. A fast automatic sorter machine had also been described. The sorter is outlined in the figure. It has two sets of aligned tubes. The lower ones are step by step moving in the direction showed by the arrow and the coin-like units are dropped from the upper source tubes into the lower destination ones. The tubes may serve as reaction vessels too. A software had also been developed that can direct sorting if not a full combinatorial library is synthesized only a set of its components are prepared that are picked out from the full library.
==== Food ==== In 2018, world production of poppy seeds for consumption was 76,240 tonnes, led by Turkey with 35% of the world total (table). Poppy seed production and trade are susceptible to fluctuations mainly due to unstable yields. The performance of most genotypes of Papaver somniferum is very susceptible to environmental changes. This behaviour led to a stagnation of the poppy seed market value between 2008 and 2009 as a consequence of high stock levels, bad weather and poor quality. The world leading importer of poppy seed is India (16 000 tonnes), followed by Russia, Poland and Germany. Poppy seed oil remains a niche product due to the lower yield compared to conventional oil crops.
Sources: en.wikipedia.org
This exchange was achieved without engineering the interpeptide docking sites. These whole-subunit exchanges have been coupled with the deletion of the Glu12-methyltransferase gene, with module exchanges at intradomain linker sites at Ala8 and Ser11, and with variations of natural fatty-acid side chains to generate over 70 novel lipopeptides in significant quantities; most of these resultant lipopeptides have potent antibacterial activities. Some of these compounds have in vitro antibacterial activities analogous to daptomycin. Further, one displayed ameliorated activity against an E. coli imp mutant that was defective in its ability to assemble its inherent lipopolysaccharide. A number of these compounds were produced in yields that spanned from 100 to 250 mg/liter; this, of course, opens up the possibility for successful scale-ups by fermentation techniques. Only a small percentage of the possible combinations of amino acids within the peptide core have been investigated thus far.
Extremely high levels of serotonin or activation of certain serotonin receptors can cause a condition known as serotonin syndrome, with toxic and potentially fatal effects. In practice, such toxic levels are essentially impossible to reach through an overdose of a single antidepressant drug, but require a combination of serotonergic agents, such as an SSRI with a MAOI, which may occur in therapeutic doses. However, serotonin syndrome can occur with overdose of certain serotonin receptor agonists, like the NBOMe series of serotonergic psychedelics. The intensity of the symptoms of serotonin syndrome vary over a wide spectrum, and the milder forms are seen even at nontoxic levels. It is estimated that 14% of patients experiencing serotonin syndrome overdose on SSRIs; while the fatality rate is between 2% and 12%.
=== Coordinated healing === DeMarco’s animal studies showed a healing phenomenon he termed "coordinated healing". Observing that animal wounds would heal differently when treated with his formula, he tried to explain his observations: after excising a square inch of skin from a rabbit’s shaved back, he would allow it to heal normally while documenting its progress with time-lapse photography. DeMarco then performed the same experiment while treating the rabbit with his formula. He observed that the untreated wound healed haphazardly; closing in a non-circular pattern with uneven levels and with infiltrating hair growth before wound closure. In contrast, the treated rabbit shows healing in a smooth circular pattern with even levels and only after wound closure would the hair begin to regrow.
=== Removal from mounting sheet === Unattached specimens are removed from the herbaria sheet by humidifying it to make them pliable and removing the plant with a paper lifter (smooth wooden spatula). They are then placed to dry and flatten along with the original mounting sheet and written documentation (label and annotations). The specimen and original documents are then remounted to a new sheet using the original sheet as reference.
Sources: en.wikipedia.org
wrapped up the two-and-a-half-month Battle of Okinawa (which cost the lives of 260,000 people, including 150,000 civilians), it was faced with the prospect of invading the Japanese home islands in an operation codenamed Operation Downfall. Based on the U.S. casualties from the preceding island-hopping campaigns, American commanders estimated that between 50,000 and 500,000 U.S. troops would die and at least 600,000–1,000,000 others would be injured while invading the Japanese home islands. The U.S. manufacture of 500,000 Purple Hearts from the anticipated high level of casualties during the U.S. invasion of Japan gave a demonstration of how deadly and costly it would be. President Harry S. Truman realized he could not afford such a high casualty rate, especially since over 400,000 American combatants had already died fighting in both the European and the Pacific theaters of the war. On July 26, 1945, the United States, the United Kingdom, and the Republic of China issued a Potsdam Declaration that called for the unconditional surrender of Japan. It stated that if Japan did not surrender, it would face "prompt and utter destruction". The Japanese government ignored this ultimatum, sending a message that they were not going to surrender. In response to the rejection, President Truman authorized the dropping of the atomic bombs. At the time of its use, there were only two atomic bombs available, and despite the fact that more were in production back in mainland U.S., the third bomb wouldn't be available for combat until September.
== Bibliography == Move That Mountain (1976), ISBN 978-0-88270-164-6 Eight Keys to Success (1980), ISBN 978-0-89221-071-8 I Was Wrong (1996), ISBN 978-0-7852-7425-4 Prosperity and the Coming Apocalypse (1998), ISBN 978-1-4185-5422-4 The Refuge: The Joy of Christian Community in a Torn-Apart World (2000), ISBN 978-1-4185-5423-1 Time Has Come: How to Prepare Now for Epic Events Ahead (2014), ISBN 978-1-61795-134-3 You Can Make It: God's Faithfulness in Dark Times-Past, Present and Future (2021), ISBN 978-1-63641-047-0
==== Inhalation and smoking ==== Results from epidemiological studies indicate that the risk of lung cancer increases with exposure to residential radon. One well known potential source of error in these studies is smoking, which is the main risk factor for lung cancer. In the US, cigarette smoking is estimated to cause 80% to 90% of all lung cancers. Radon, like other known or suspected external risk factors for lung cancer, is a threat for smokers and former smokers. According to the EPA, the risk of lung cancer for smokers is significantly higher when they are exposed to radon due to the synergistic effects of radon with smoking. For this population, about 62 people in a total of 1,000 will die of lung cancer, compared to 7 people in a total of 1,000 for people who have never smoked. A 2005 review article by Darby and colleagues analyzing 13 different case studies across Europe stated: "It is not appropriate to talk simply of a risk from radon in homes. The risk is from smoking, compounded by a synergistic effect of radon for smokers. Without smoking, the effect seems to be so small as to be insignificant." According to Darby, there is a difference in risk for the histological subtypes of lung cancer and radon exposure. Small-cell lung carcinoma, which has a high correlation with smoking, has a higher risk after radon exposure. For other histological subtypes, such as adenocarcinoma, the type that primarily affects non-smokers, the risk from radon appears to be lower.
Ephedrine is a sympathomimetic amine similar in molecular structure to the well-known drugs phenylpropanolamine and methamphetamine, as well as to the important neurotransmitter epinephrine (adrenaline). Ephedrine is commonly used as a stimulant, appetite suppressant, concentration aid, and decongestant, and to treat hypotension associated with anesthesia. In chemical terms, it is an alkaloid with a phenethylamine skeleton found in various plants in the genus Ephedra (family Ephedraceae). Ephedrine works mainly by increasing the activity of norepinephrine (noradrenaline) on adrenergic receptors. It is most usually marketed as the hydrochloride or sulfate salt. The herb má huáng (Ephedra sinica), used in traditional Chinese medicine (TCM), contains ephedrine and pseudoephedrine as its principal active constituents. The same may be true of other herbal products containing extracts from other Ephedra species.
In dependent smokers, withdrawal causes impairments in memory and attention, and smoking during withdrawal returns these cognitive abilities to pre-withdrawal levels. The temporarily increased cognitive levels of smokers after inhaling smoke are offset by periods of cognitive decline during nicotine withdrawal. Therefore, the overall daily cognitive levels of smokers and non-smokers are roughly similar. Nicotine activates the mesolimbic pathway and induces long-term ΔFosB expression (i.e., produces phosphorylated ΔFosB isoforms) in the nucleus accumbens when inhaled or injected frequently or at high doses, but not necessarily when ingested. Consequently, high daily exposure (possibly excluding oral route) to nicotine can cause ΔFosB overexpression in the nucleus accumbens, resulting in nicotine addiction.
Sources: en.wikipedia.org
特沙莫瑞林是国际非专利名称,指一种经过 N 端修饰的生长激素释放激素类似物。它被归类为合成肽,序列与 GHRH(1-44) 密切相关。该名称不指代任何特定品牌或剂型。
监管批准集中于 HIV 感染相关的脂肪营养不良,目的是减少内脏脂肪。它未被批准用于普通肥胖或一般体重管理。不同国家的批准状态和标签范围可能不同。
长期心血管获益、死亡率影响以及停药后的持续性仍缺乏确证。部分研究提示 IGF-1 和血糖参数可能变化,但个体差异较大。这些开放问题需要更长期、更大规模的试验来回答。
It targets the growth hormone-releasing hormone receptor on pituitary somatotroph cells. Binding stimulates cyclic AMP signaling and growth hormone secretion. This is the same receptor used by endogenous GHRH.